-
1
-
-
0029876674
-
Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome
-
Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 1996; 75: 224-8.
-
(1996)
Thromb Haemost
, vol.75
, pp. 224-228
-
-
Gando, S.1
Kameue, T.2
Nanzaki, S.3
Nakanishi, Y.4
-
2
-
-
0026534242
-
Septic shock, multiple organ failure, and disseminated intravascular coagulation: Compared patterns of antithrombin III, protein C, and protein S deficiences
-
Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P. Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C, and protein S deficiences. Chest 1992; 101: 816-23.
-
(1992)
Chest
, vol.101
, pp. 816-823
-
-
Fourrier, F.1
Chopin, C.2
Goudemand, J.3
Hendrycx, S.4
Caron, C.5
Rime, A.6
Marey, A.7
Lestavel, P.8
-
3
-
-
0033584457
-
Disseminated intravascular coagulation
-
Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.
-
(1999)
N Engl J Med
, vol.341
, pp. 586-592
-
-
Levi, M.1
Ten Cate, H.2
-
4
-
-
1842285734
-
Isolation of cDNA clones coding for human tissue factor: Primary structure of the protein and cDNA
-
Spicer EK, Horton R, Bloem L, Bach R, Williams KR, Guha A, Kraus J, Lin TC, Nemerson Y, Konigsberg WH. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci USA 1987; 84: 5148-52.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 5148-5152
-
-
Spicer, E.K.1
Horton, R.2
Bloem, L.3
Bach, R.4
Williams, K.R.5
Guha, A.6
Kraus, J.7
Lin, T.C.8
Nemerson, Y.9
Konigsberg, W.H.10
-
5
-
-
0001495165
-
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
-
Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-43.
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 2839-2843
-
-
Wilcox, J.N.1
Smith, K.M.2
Schwartz, S.M.3
Gordon, D.4
-
6
-
-
0023774854
-
Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine
-
Carlsen E, Flatmark A, Prydz H. Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine. Transplantation 1988; 46: 575-80.
-
(1988)
Transplantation
, vol.46
, pp. 575-580
-
-
Carlsen, E.1
Flatmark, A.2
Prydz, H.3
-
7
-
-
0016790233
-
The endotoxin-induced coagulant activity of human monocytes
-
Rivers RP, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975; 30: 311-6.
-
(1975)
Br J Haematol
, vol.30
, pp. 311-316
-
-
Rivers, R.P.1
Hathaway, W.E.2
Weston, W.L.3
-
8
-
-
0021199320
-
Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
-
Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984; 160: 618-23.
-
(1984)
J Exp Med
, vol.160
, pp. 618-623
-
-
Bevilacqua, M.P.1
Pober, J.S.2
Majeau, G.R.3
Cotran, R.S.4
Gimbrone M.A, Jr.5
-
9
-
-
0000555820
-
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1
-
Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA, Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83: 4533-7.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 4533-4537
-
-
Bevilacqua, M.P.1
Pober, J.S.2
Majeau, G.R.3
Fiers, W.4
Cotran, R.S.5
Gimbrone M.A., Jr.6
-
10
-
-
0023089665
-
Endotoxin enhances tissue factor and suppresses thrombomoduline expression of human vascular endothelium in vitro
-
Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomoduline expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-30.
-
(1987)
J Clin Invest
, vol.79
, pp. 124-130
-
-
Moore, K.L.1
Andreoli, S.P.2
Esmon, N.L.3
Esmon, C.T.4
Bang, N.U.5
-
11
-
-
0020658537
-
Increased thromboplastin activity in monocytes of patients with meningococcal infections: Related to unfavorable prognosis
-
Osterud B, Flaegstad T. Increased thromboplastin activity in monocytes of patients with meningococcal infections: related to unfavorable prognosis. Thromb Haemost 1983; 49: 5-7.
-
(1983)
Thromb Haemost
, vol.49
, pp. 5-7
-
-
Osterud, B.1
Flaegstad, T.2
-
12
-
-
0023280095
-
Mononuclear phagocyte thromboplastin and endotoxin in patients with secondary peritonitis
-
Almdahl SM, Brox JH, Osterud B. Mononuclear phagocyte thromboplastin and endotoxin in patients with secondary peritonitis. Scan J Gastroenterol 1987; 22: 914-8.
-
(1987)
Scan J Gastroenterol
, vol.22
, pp. 914-918
-
-
Almdahl, S.M.1
Brox, J.H.2
Osterud, B.3
-
13
-
-
85034899439
-
Increased procoagulant activity of peripheral blood monocytes in human and experimental obstructive jaundice
-
Semeraro N, Montemurro P, Chetta G, Altomare DF, Giordano G, Colucci M. Increased procoagulant activity of peripheral blood monocytes in human and experimental obstructive jaundice. Gastroenterology 1989; 96: 892-8.
-
(1989)
Gastroenterology
, vol.96
, pp. 892-898
-
-
Semeraro, N.1
Montemurro, P.2
Chetta, G.3
Altomare, D.F.4
Giordano, G.5
Colucci, M.6
-
14
-
-
0025904459
-
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
-
Taylor FB Jr., Chang ACK, Ruf W, Morrisey JH, Hinshaw L, Catlett R, Blick K, Edgington TS. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127-34.
-
(1991)
Circ Shock
, vol.33
, pp. 127-134
-
-
Taylor F.B., Jr.1
Chang, A.C.K.2
Ruf, W.3
Morrisey, J.H.4
Hinshaw, L.5
Catlett, R.6
Blick, K.7
Edgington, T.S.8
-
15
-
-
0028006127
-
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees
-
Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Büller HR, van Deventer SJH, Hack CE, ten Cate JW, Rosenberg RD. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93: 114-20.
-
(1994)
J Clin Invest
, vol.93
, pp. 114-120
-
-
Levi, M.1
Ten Cate, H.2
Bauer, K.A.3
Van Der Poll, T.4
Edgington, T.S.5
Büller, H.R.6
Van Deventer, S.J.H.7
Hack, C.E.8
Ten Cate, J.W.9
Rosenberg, R.D.10
-
16
-
-
0028895452
-
Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa
-
Biemond BJ, Levi M, ten Cate H, Soule HR, Morris LD, Foster DL, Bogowitz CA, van der Poll T, Büller HR, ten Cate JW. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. Thromb Haemost 1995; 73: 223-30.
-
(1995)
Thromb Haemost
, vol.73
, pp. 223-230
-
-
Biemond, B.J.1
Levi, M.2
Ten Cate, H.3
Soule, H.R.4
Morris, L.D.5
Foster, D.L.6
Bogowitz, C.A.7
Van Der Poll, T.8
Büller, H.R.9
Ten Cate, J.W.10
-
17
-
-
2642638788
-
Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 E. coli
-
Taylor FB Jr, Chang ACK, Peer GT, Li A, Ezban M, Hedner U. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 E. coli. Blood 1998; 91: 1609-15.
-
(1998)
Blood
, vol.91
, pp. 1609-1615
-
-
Taylor F.B., Jr.1
Chang, A.C.K.2
Peer, G.T.3
Li, A.4
Ezban, M.5
Hedner, U.6
-
18
-
-
0027319678
-
Tissue factor pathway inhibitor reduces mortality from E. coli septic shock
-
Creasey AA, Chang ACK, Feigen L, Wun T-C, Taylor FB, Jr, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from E. coli septic shock. J Clin Invest 1993; 91: 2850-60.
-
(1993)
J Clin Invest
, vol.91
, pp. 2850-2860
-
-
Creasey, A.A.1
Chang, A.C.K.2
Feigen, L.3
Wun, T.-C.4
Taylor F.B., Jr.5
Hinshaw, L.B.6
-
19
-
-
0028627767
-
Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock
-
Carr C, Bild GS, Chang AC, Peer GT, Palmier MO, Frazier RB, Gustafson ME, Wun TC, Creasey AA, Hinshaw LB. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock. Circ Shock 1994: 44: 126-37.
-
(1994)
Circ Shock
, vol.44
, pp. 126-137
-
-
Carr, C.1
Bild, G.S.2
Chang, A.C.3
Peer, G.T.4
Palmier, M.O.5
Frazier, R.B.6
Gustafson, M.E.7
Wun, T.C.8
Creasey, A.A.9
Hinshaw, L.B.10
-
20
-
-
0031977806
-
Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli
-
Randolph MM, White GL, Kosanke SD, Bild G, Carr C, Galluppi G, Hinshaw LB, Taylor FB Jr. Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli. Thromb Haemost 1998; 79: 1048-53.
-
(1998)
Thromb Haemost
, vol.79
, pp. 1048-1053
-
-
Randolph, M.M.1
White, G.L.2
Kosanke, S.D.3
Bild, G.4
Carr, C.5
Galluppi, G.6
Hinshaw, L.B.7
Taylor F.B., Jr.8
-
21
-
-
18844480902
-
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
-
de Jonge E, Dekkers PEP, Creasey AA, Hack CE, Paulson SK, Karim A, Kesecioglu J, Levi M, van Deventer SJH, van der Poll T. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood 2000; 95: 1124-9.
-
(2000)
Blood
, vol.95
, pp. 1124-1129
-
-
De Jonge, E.1
Dekkers, P.E.P.2
Creasey, A.A.3
Hack, C.E.4
Paulson, S.K.5
Karim, A.6
Kesecioglu, J.7
Levi, M.8
Van Deventer, S.J.H.9
Van Der Poll, T.10
-
22
-
-
0035159740
-
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study
-
Abraham E, Reinhart K, Svoboda P, Seibert A, Olthoff D, Dalk Nogare A, Postier R, Hempelmann G, Butler T, Martin E, Zwingelstein C, Percell S, Shu V, Leighton A, Creasey AA. Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med 2001; 29: 2081-9.
-
(2001)
Crit Care Med
, vol.29
, pp. 2081-2089
-
-
Abraham, E.1
Reinhart, K.2
Svoboda, P.3
Seibert, A.4
Olthoff, D.5
Dalk Nogare, A.6
Postier, R.7
Hempelmann, G.8
Butler, T.9
Martin, E.10
Zwingelstein, C.11
Percell, S.12
Shu, V.13
Leighton, A.14
Creasey, A.A.15
-
23
-
-
0000455702
-
Anticoagulant repertoire of the hookworm Ancylostoma caninum
-
Stassens P, Bergum PW, Gansemans Y, Jespers L, Laroche Y, Huang S, Maki S, Messens J, Lauwereys M, Capello M, Hotez PJ, Lasters I, Vlasuk GP. Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc Natl Acad Sci USA 1996; 93: 2149-54.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 2149-2154
-
-
Stassens, P.1
Bergum, P.W.2
Gansemans, Y.3
Jespers, L.4
Laroche, Y.5
Huang, S.6
Maki, S.7
Messens, J.8
Lauwereys, M.9
Capello, M.10
Hotez, P.J.11
Lasters, I.12
Vlasuk, G.P.13
-
24
-
-
0035971227
-
Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2 (rNAPc2)
-
Bergum PW, Cruikshank A, Maki SL, Kelly CR, Ruf W, Vlasuk GP. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2 (rNAPc2). J Biol Chem 2001; 276: 10063-71.
-
(2001)
J Biol Chem
, vol.276
, pp. 10063-10071
-
-
Bergum, P.W.1
Cruikshank, A.2
Maki, S.L.3
Kelly, C.R.4
Ruf, W.5
Vlasuk, G.P.6
-
25
-
-
0035800075
-
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement
-
Lee A, Agnelli G, Büller HR, Ginsberg J, Heit J, Rote W, Vlasuk G, Costantini L, Julian J, Comp P, van der Meer J, Piovella F, Raskob G, Gent M. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation 2001; 104: 74-8.
-
(2001)
Circulation
, vol.104
, pp. 74-78
-
-
Lee, A.1
Agnelli, G.2
Büller, H.R.3
Ginsberg, J.4
Heit, J.5
Rote, W.6
Vlasuk, G.7
Costantini, L.8
Julian, J.9
Comp, P.10
Van Der Meer, J.11
Piovella, F.12
Raskob, G.13
Gent, M.14
-
26
-
-
0024444125
-
Detection of factor X activation in humans
-
Bauer KA, Kass BL, ten Cate H, Bednarek MA, Hawiger JJ, Rosenberg RD. Detection of Factor X activation in humans. Blood 1989; 74: 2007-15.
-
(1989)
Blood
, vol.74
, pp. 2007-2015
-
-
Bauer, K.A.1
Kass, B.L.2
Ten Cate, H.3
Bednarek, M.A.4
Hawiger, J.J.5
Rosenberg, R.D.6
-
27
-
-
0024997547
-
Factor IX is activated in vivo by the tissue factor mechanism
-
Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990; 76: 731-6.
-
(1990)
Blood
, vol.76
, pp. 731-736
-
-
Bauer, K.A.1
Kass, B.L.2
Ten Cate, H.3
Hawiger, J.J.4
Rosenberg, R.D.5
-
28
-
-
79960971663
-
A blinded, dose-escalating phase IIa study of the fVII/tissue factor inhibitor rNAPc2 in patients undergoing elective percutaneous coronary angioplasty
-
(abstract)
-
Moons A, Bijsterveld N, Büller H, Prins M, Rote WE, Vlasuk GP, Peters RJ. A blinded, dose-escalating phase IIa study of the fVII/tissue factor inhibitor rNAPc2 in patients undergoing elective percutaneous coronary angioplasty. Blood 2001; 98: 707a (abstract).
-
(2001)
Blood
, vol.98
-
-
Moons, A.1
Bijsterveld, N.2
Büller, H.3
Prins, M.4
Rote, W.E.5
Vlasuk, G.P.6
Peters, R.J.7
-
29
-
-
0035868253
-
Anti- and procoagulant activities in factor VII-deficient subjects
-
Astermark J, Tengborn L, Hedner U, Berntorp E. Anti- and procoagulant activities in factor VII-deficient subjects. Thromb Res 2001; 101: 435-40.
-
(2001)
Thromb Res
, vol.101
, pp. 435-440
-
-
Astermark, J.1
Tengborn, L.2
Hedner, U.3
Berntorp, E.4
-
30
-
-
0025647250
-
Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
-
van Deventer SJ, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520-6.
-
(1990)
Blood
, vol.76
, pp. 2520-2526
-
-
Van Deventer, S.J.1
Büller, H.R.2
Ten Cate, J.W.3
Aarden, L.A.4
Hack, C.E.5
Sturk, A.6
-
31
-
-
0025303041
-
Activation of coagulation after administration of tumor necrosis factor to normal subjects
-
van der Poll T, Büller HR, ten Cate H, Wortel CA, Bauer KA, van Deventer SJ, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322: 1622-7.
-
(1990)
N Engl J Med
, vol.322
, pp. 1622-1627
-
-
Van Der Poll, T.1
Büller, H.R.2
Ten Cate, H.3
Wortel, C.A.4
Bauer, K.A.5
Van Deventer, S.J.6
Hack, C.E.7
Sauerwein, H.P.8
Rosenberg, R.D.9
Ten Cate, J.W.10
-
32
-
-
0028323245
-
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
-
van der Poll T, Levi M. Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Büller HR, ten Cate JW, Aarden LA. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179: 1253-9.
-
(1994)
J Exp Med
, vol.179
, pp. 1253-1259
-
-
Van Der Poll, T.1
Levi, M.2
Hack, C.E.3
Ten Cate, H.4
Van Deventer, S.J.5
Eerenberg, A.J.6
De Groot, E.R.7
Jansen, J.8
Gallati, H.9
Büller, H.R.10
Ten Cate, J.W.11
Aarden, L.A.12
-
33
-
-
0029041753
-
Plasminogen activator and plasminogen activator inhibitor 1 release during experimental endotoxemia in chimpanzees: Effect of interventions in the cytokine and coagulation cascades
-
Biemond BJ, Levi M, ten Cate H, van der Poll T, Büller HR, Hack CE, ten Cate JW. Plasminogen activator and plasminogen activator inhibitor 1 release during experimental endotoxemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Sci 1995; 88: 587-94.
-
(1995)
Clin Sci
, vol.88
, pp. 587-594
-
-
Biemond, B.J.1
Levi, M.2
Ten Cate, H.3
Van Der Poll, T.4
Büller, H.R.5
Hack, C.E.6
Ten Cate, J.W.7
-
34
-
-
0024562002
-
Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects
-
Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 320: 1165-72.
-
(1989)
N Engl J Med
, vol.320
, pp. 1165-1172
-
-
Suffredini, A.F.1
Harpel, P.C.2
Parrillo, J.E.3
-
35
-
-
0027953316
-
Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees
-
van der Poll T, Levi M, van Deventer SJ, ten Cate H, Haagmans BL, Biemond BJ, Büller HR, Hack CE, ten Cate JW. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood 1994; 83: 446-51.
-
(1994)
Blood
, vol.83
, pp. 446-451
-
-
Van Der Poll, T.1
Levi, M.2
Van Deventer, S.J.3
Ten Cate, H.4
Haagmans, B.L.5
Biemond, B.J.6
Büller, H.R.7
Hack, C.E.8
Ten Cate, J.W.9
-
36
-
-
17044458176
-
Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans
-
van der Poll T, Coyle SM, Levi M, Jansen PM, Dentener M, Barbosa K, Buurman WA, Hack CE, ten Cate JW, Agosti JM, Lowry SF. Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood 1997; 89: 3727-34.
-
(1997)
Blood
, vol.89
, pp. 3727-3734
-
-
Van Der Poll, T.1
Coyle, S.M.2
Levi, M.3
Jansen, P.M.4
Dentener, M.5
Barbosa, K.6
Buurman, W.A.7
Hack, C.E.8
Ten Cate, J.W.9
Agosti, J.M.10
Lowry, S.F.11
-
37
-
-
0031878665
-
Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans
-
DeLa Cadena RA, Majluf-Cruz A, Stadnicki A, Tropea M, Reda D, Agosti JM, Colman RW, Suffredini AF. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans. Thromb Haemost 1998; 80: 114-8.
-
(1998)
Thromb Haemost
, vol.80
, pp. 114-118
-
-
De La Cadena, R.A.1
Majluf-Cruz, A.2
Stadnicki, A.3
Tropea, M.4
Reda, D.5
Agosti, J.M.6
Colman, R.W.7
Suffredini, A.F.8
-
38
-
-
0026559504
-
Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C
-
Taylor FB Jr, Hoogendoorn H, Chang ACK, Peer G, Nesheim ME, Catlett R, Stump DC, Giles AR. Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C. Blood 79: 1720-8.
-
Blood
, vol.79
, pp. 1720-1728
-
-
Taylor F.B., Jr.1
Hoogendoorn, H.2
Chang, A.C.K.3
Peer, G.4
Nesheim, M.E.5
Catlett, R.6
Stump, D.C.7
Giles, A.R.8
|